Status:
TERMINATED
A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine
Lead Sponsor:
GlaxoSmithKline
Conditions:
Hepatitis A
Eligibility:
All Genders
6-27 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the efficacy in young children in preventing acute otitis media due to vaccine serotype pneumococcal or non typable Hemophilus influenza, following immunization ...
Eligibility Criteria
Inclusion
- Male or female between 6 weeks and 5 months (42-152 days) of age at the time of first vaccination.
Exclusion
- Use of any investigational or non-registered drug or vaccine other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period.
Key Trial Info
Start Date :
October 1 2000
Trial Type :
INTERVENTIONAL
End Date :
June 1 2004
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00119743
Start Date
October 1 2000
End Date
June 1 2004
Last Update
March 23 2017
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Brno, Czechia, 628 00
2
GSK Investigational Site
České Budějovice, Czechia, 370 71
3
GSK Investigational Site
Děčín, Czechia, 405 01
4
GSK Investigational Site
Fryštát, Czechia, 734 01